Date Time
Supporting those with extreme reactions to COVID vaccines
A vaccination scheme to compensate people who have serious reactions to COVID vaccines and other types of vaccinations administered in Australia would be useful, according to a researcher from The University of Western Australia.
The AstraZeneca and Pfizer vaccines, which are being used in Australia, have been associated with a very small number of adverse reactions. However even though the numbers are low, recent reports of reactions have resulted in some community concern and hesitancy over vaccine uptake.
“The pandemic provides us with a window of opportunity, where the government could introduce a COVID-specific scheme, and potentially expand it to include other vaccinations”
Date Time
Share
Victor Chang Cardiac Research Institute Scientists in Western Australia Awarded $500,000 to accelerate new treatment into ‘big heart
Victor Chang Cardiac Research Institute
The funding boost by global biotech giant CSL will be used to drive research into hypertrophic cardiomyopathy, the world’s leading cause of cardiac death for children aged between five and 15.
It is hoped the award will help Professor Livia Hool and her WA based team deliver through on their breakthrough discovery, which could potentially both prevent and reverse the damage of the inherited heart disease which causes the heart to become dangerously large.
“This disease affects around one in 500 people and could be as common as one in every 200. It’s shocking that we have no way of preventing or reversing the damage to the heart. All we can do now is alleviate the symptoms,” says Professor Livia Hool.
【未解之谜】史前壁画两亿年脚印 挑战进化论 | 扶摇 | 史前文明 | 岩石壁画 epochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epochtimes.com Daily Mail and Mail on Sunday newspapers.
Australia needs to start producing mRNA vaccines
27 Apr 2021 | 3 mins (including 1 min video)
It could take as little as three months for Australia to begin local production of COVID-19 mRNA vaccines such as Pfizer, according to Associate Professor Archa Fox, from The University of Western Australia’s School of Human Sciences and School of Molecular Sciences.
Associate Professor Fox, who is also RnA Network of Australasia president, said the estimate was based on the precedent of a factory that was repurposed in Germany, where they had a three-month turnaround.
“This was an undertaking that was done by
Pfizer
/BioNTech to make a factory that could make from one billion doses of mRNA vaccine a year,” she said.